Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.01 -0.02 (-0.04%)
Streaming Delayed Price Updated: 9:54 AM EST, Dec 27, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
March 30, 2006
Form 10KSB
Source: SEC/Edgar
March 23, 2006
Form 8-K
Source: SEC/Edgar
March 23, 2006
Form SC 13D/A
Source: SEC/Edgar
March 22, 2006
Form SC 13D
Source: SEC/Edgar
March 22, 2006
Form SC 13D/A
Source: SEC/Edgar
March 22, 2006
Form 8-K
Source: SEC/Edgar
March 19, 2006
Form 425
Source: SEC/Edgar
March 19, 2006
Form POS AM
Source: SEC/Edgar
March 16, 2006
Form PRE 14A
Source: SEC/Edgar
March 16, 2006
Form 425
Source: SEC/Edgar
March 13, 2006
Form 425
Source: SEC/Edgar
March 13, 2006
Form 8-K
Source: SEC/Edgar
March 13, 2006
Form DEF 14C
Source: SEC/Edgar
March 12, 2006
Form 8-K
Source: SEC/Edgar
March 06, 2006
Form SC 13G
Source: SEC/Edgar
March 02, 2006
Form PRE 14C
Source: SEC/Edgar
February 28, 2006
Form 8-K
Source: SEC/Edgar
February 20, 2006
Form 8-K
Source: SEC/Edgar
February 16, 2006
Form 8-K
Source: SEC/Edgar
February 16, 2006
Form NT 10-Q
Source: SEC/Edgar
February 14, 2006
Form 10QSB
Source: SEC/Edgar
February 14, 2006
Form SC 13G/A
Source: SEC/Edgar
February 12, 2006
Form 8-K
Source: SEC/Edgar
February 07, 2006
Form SC 13G/A
Source: SEC/Edgar
February 06, 2006
Form 8-K
Source: SEC/Edgar
February 02, 2006
Form 8-K
Source: SEC/Edgar
February 01, 2006
Form 8-K
Source: SEC/Edgar
January 31, 2006
Form SC 13G/A
Source: SEC/Edgar
January 26, 2006
Form 8-K
Source: SEC/Edgar
January 19, 2006
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.